Bicocca Open Archive

Logo unimib boa
PAGAN, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.595
EU - Europa 1.572
AS - Asia 526
AF - Africa 4
OC - Oceania 4
SA - Sud America 3
Totale 4.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.573
DE - Germania 537
IT - Italia 348
SE - Svezia 233
IE - Irlanda 167
CN - Cina 161
HK - Hong Kong 112
RU - Federazione Russa 108
VN - Vietnam 92
SG - Singapore 73
GB - Regno Unito 52
FR - Francia 37
IN - India 30
ID - Indonesia 27
UA - Ucraina 23
CA - Canada 22
DK - Danimarca 21
FI - Finlandia 12
NL - Olanda 6
BE - Belgio 5
JP - Giappone 5
KR - Corea 5
AU - Australia 4
MY - Malesia 4
PK - Pakistan 4
BG - Bulgaria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
ES - Italia 3
IL - Israele 3
RO - Romania 3
TR - Turchia 3
AT - Austria 2
BR - Brasile 2
HU - Ungheria 2
IR - Iran 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BJ - Benin 1
GR - Grecia 1
JO - Giordania 1
NG - Nigeria 1
PL - Polonia 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.704
Salva come PNG Salva come JPEG
Città #
Ann Arbor 818
Frankfurt am Main 508
Fairfield 259
Wilmington 210
Dublin 158
Houston 131
Ashburn 125
Chandler 116
Hong Kong 111
Milan 107
Seattle 100
Woodbridge 94
New York 92
Princeton 88
Cambridge 78
Dearborn 54
Dong Ket 49
Altamura 45
Lawrence 43
Singapore 41
San Diego 39
Shanghai 36
Jakarta 27
Nanjing 26
Beijing 23
Guangzhou 21
Chicago 17
Sacramento 17
Ardea 16
Jacksonville 16
Andover 13
Umeå 12
Carate Brianza 11
London 10
Mumbai 10
Toronto 10
Helsinki 9
Redmond 9
Hangzhou 7
Monza 7
Nanchang 7
Paris 7
Pavia 7
Pune 7
Dallas 6
Ottawa 6
Boardman 5
Brussels 5
Busto Arsizio 5
College Station 5
Edmonton 5
Ningbo 5
Norwalk 5
Sorso 5
Bau 4
Bonndorf 4
Cagliari 4
Gainesville 4
Kunming 4
Marietta 4
Munich 4
Naples 4
Bologna 3
Brescia 3
Changsha 3
Cologno Monzese 3
Fremont 3
Heilbronn 3
Huskvarna 3
Kardzhali 3
Kiev 3
Laurel 3
Los Angeles 3
Rome 3
San Mateo 3
Shenyang 3
Stockholm 3
Villa Literno 3
Arco 2
Arcore 2
Arezzo 2
Bengaluru 2
Brno 2
Buccinasco 2
Budapest 2
Casorate Sempione 2
Colchester 2
Columbus 2
Confienza 2
Córdoba 2
Dehradun 2
Elk Grove 2
Elkridge 2
Falls Church 2
Fuzhou 2
Groningen 2
Guangdong 2
Hebei 2
Hefei 2
Islamabad 2
Totale 3.767
Salva come PNG Salva come JPEG
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 358
Laryngeal cancer mortality trends in European countries 235
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 202
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 199
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 195
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 194
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 182
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 176
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 172
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 166
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 163
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 137
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 135
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 128
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 114
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 114
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 104
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 101
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 99
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 94
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 92
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 87
Different Response to Immunotherapy According to Melanoma Histologic Subtype 87
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 87
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 85
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 82
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 79
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 78
Sex-based differences in cancer immunotherapy efficacy 74
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 74
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 72
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 67
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 67
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 66
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 59
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 59
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 55
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 54
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 48
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 47
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 37
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 35
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 30
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 29
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 29
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 28
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 27
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 27
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 26
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 24
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 20
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 20
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 17
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 10
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 8
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 8
Male breast cancer: a multicenter study to provide a guide for proper management 6
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 6
Totale 5.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020782 0 49 26 74 70 120 129 87 90 65 51 21
2020/20211.093 33 43 78 93 101 136 111 138 69 64 45 182
2021/2022742 81 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/2025173 129 44 0 0 0 0 0 0 0 0 0 0
Totale 5.074